Here is your complete pre-seminar preparation guide covering both topics.
Pre-Seminar Guide: Acute Pancreatitis & Fracture Management in Geriatric Patients
PART 1 - ACUTE PANCREATITIS
1. What Is It?
Acute pancreatitis (AP) is a sudden inflammatory disease of the pancreas causing significant morbidity and mortality. Approximately 40% of acute cases are recognized only at autopsy, making early diagnosis critical.
Diagnostic Criteria (any 2 of 3):
- Abdominal pain consistent with AP (epigastric, radiating to the back)
- Serum lipase or amylase >3x the upper limit of normal
- Characteristic findings on abdominal imaging (CECT or MRI)
- Serum lipase is preferred - it remains elevated up to 14 days and has >90% sensitivity. Amylase clears within 48-72 hours (sensitivity drops below 30% on days 2-4).
- Source: Textbook of Family Medicine 9e and Current Surgical Therapy 14e
2. Etiology (Know the "GET SMASHED" Causes)
| Common (>85%) | Less Common (<15%) |
|---|
| Gallstones / biliary sludge (>50%) | Hypertriglyceridemia (TG >1000 mg/dL) |
| Alcohol (~30%) | Trauma |
| ERCP (post-procedural) |
| Medications (valproate, azathioprine, thiazides, etc.) |
| Hypercalcemia |
| Infections (mumps, enteroviruses, EBV) |
| Neoplasm (always consider if age >40 years) |
| Idiopathic / Autoimmune |
Key point: Ultrasound should be done in ALL patients with AP to evaluate for gallstones.
3. Severity Classification - 2012 Revised Atlanta Classification
| Grade | Organ Failure | Complications | Mortality |
|---|
| Mild | Absent | Absent | Very rare (<5%) |
| Moderately Severe | Transient (<48 hrs) | Present, without persistent OF | Low |
| Severe | Persistent (>48 hrs) | Present | High (36-50%); extremely high with infected necrosis |
Severity evolves over time - re-evaluate at 24h, 48h, 7 days, then weekly.
Scoring Systems to Know:
- Ranson's Criteria (admission + 48h parameters) - low PPV (50%), high NPV (90%); ≥3 = severe
- APACHE II score - can be used on admission
- BISAP score (BUN >25, Impaired mental status, SIRS, Age >60, Pleural effusion) - simpler bedside tool
- CT Severity Index (CTSI) - based on degree of necrosis, inflammation, and fluid collections on CECT
- PASS (Pancreatitis Activity Scoring System) - continuous dynamic scoring
- Source: Current Surgical Therapy 14e, Rosen's Emergency Medicine
4. Local Complications (Revised Atlanta Definitions)
| Term | Timing | Key Features |
|---|
| Interstitial edematous pancreatitis | <4 weeks | Diffuse enlargement, no necrosis, homogeneous enhancement |
| Acute Peripancreatic Fluid Collection (APFC) | <4 weeks | No defined wall, no necrosis |
| Pancreatic Pseudocyst | >4 weeks | Well-defined wall, homogeneous fluid, minimal necrosis |
| Necrotizing Pancreatitis | <4 weeks | Non-enhancing parenchyma on CECT (the key sign) |
| Acute Necrotic Collection (ANC) | <4 weeks | Heterogeneous, fluid + necrosis, no wall |
| Walled-Off Necrosis (WON) | >4 weeks | Encapsulated necrosis, well-defined wall |
Systemic complications: AKI, respiratory failure, sepsis, abdominal compartment syndrome, splenic/portal vein thrombosis.
5. Imaging
- CECT is the gold standard for confirming diagnosis, assessing necrosis, and identifying complications
- Gas within a necrotic collection on CT = infected necrosis (urgent intervention trigger)
- Repeat CT at 48-72h if patient fails to improve; weekly if complications exist
- MRCP/EUS for suspected choledocholithiasis when bilirubin is normal (avoids ERCP risk)
- Source: Current Surgical Therapy 14e
6. Management
Fluid Resuscitation:
- Early aggressive IV fluids are the single most important intervention
- Preferred fluid: Ringer's Lactate (antiinflammatory, less metabolic acidosis vs. normal saline)
- Rate: 250-500 mL/hr (5-10 mL/kg/hr), titrate to HR, MAP, urine output
- Target: decrease BUN, normalize hematocrit (hemoconcentration = third spacing)
- Monitor for volume overload (pleural effusion, edema, hypoxia)
Antibiotics:
- NOT indicated empirically or prophylactically
- Only indicated when infected necrosis is documented (positive culture or gas on CT)
- Preferred: Carbapenems (best pancreatic tissue penetration vs. cephalosporins or fluoroquinolones)
- Probiotics are contraindicated (doubled mortality in one RCT - likely due to intestinal ischemia)
Nutrition:
- Early oral feeding <24 hours if tolerated is NOW recommended (replaces old NPO approach)
- If oral not tolerated: nasogastric or nasojejunal feeding equally effective
- Enteral nutrition is strongly preferred over TPN - reduces infection, organ failure, need for surgery, and mortality
Biliary / ERCP:
- ERCP within 24h only for concurrent acute cholangitis or biliary obstruction
- Early laparoscopic cholecystectomy (within 3 days) is standard of care for mild biliary pancreatitis
- Source: Current Surgical Therapy 14e, Sleisenger & Fordtran's GI & Liver Disease
7. Step-Up Approach for Necrotizing Pancreatitis
This is the current standard of care - replacing emergent open necrosectomy:
Step 1: Percutaneous or endoscopic drainage of infected/symptomatic collection
Step 2: Endoscopic necrosectomy (video-assisted retroperitoneal debridement - VARD)
Step 3: Minimally invasive or open surgical necrosectomy (only if steps 1 & 2 fail)
Timing rules:
- Mortality of surgery in first 2 weeks: 75%
- Mortality at 2-4 weeks: 45%
- Mortality after 30 days: 8%
- Optimal drainage timing: at least 4 weeks after onset to allow "walled-off" maturation
- Exception: clinical deterioration with infected necrosis = urgent percutaneous drainage regardless of timing
8. Latest Guidelines (2025)
The
IAP/APA/EPC Revised AP Guidelines 2025 (PMID: 40651900) and the
ACG Guidelines 2024 (PMID: 38857482) are the most current authoritative references - worth reviewing before the seminar.
PART 2 - FRACTURE MANAGEMENT IN GERIATRIC PATIENTS
1. Why Geriatric Fractures Are Different
Elderly patients have multiple unique risk factors that alter both the injury pattern and the management approach:
- Osteoporosis - low bone density makes fragility fractures (low-energy trauma) the norm
- Multiple comorbidities - cardiac disease, diabetes, renal impairment, anticoagulation
- Polypharmacy - increased bleeding risk, drug interactions
- Reduced physiologic reserve - poor tolerance of prolonged immobility, anesthesia risk
- Cognitive impairment - affects consent, rehabilitation compliance, pain reporting
- Increased risk of delirium perioperatively
2. Common Fracture Types in the Elderly
| Fracture | Typical Mechanism | Notes |
|---|
| Hip fracture (femoral neck / intertrochanteric) | Fall from standing height | Most common, highest mortality |
| Vertebral compression fracture | Minimal or no trauma | Often missed; back pain in osteoporosis |
| Distal radius (Colles) | Fall on outstretched hand | Often first sign of osteoporosis |
| Proximal humerus | Fall | Conservative vs. surgical depending on displacement |
| Pubic rami / pelvis | Low-energy fall | Often managed conservatively |
3. Hip Fracture - The Most Important Geriatric Fracture
Classification:
- Intracapsular (femoral neck) - risk of avascular necrosis; managed with hemiarthroplasty or total hip replacement in elderly
- Extracapsular (intertrochanteric / subtrochanteric) - managed with intramedullary nailing or dynamic hip screw (DHS)
Key principles:
- Surgery is the definitive treatment in almost all cases (immobility = VTE, pneumonia, pressure sores, rapid decline)
- WHO benchmark: Surgery within 48 hours of admission (endorsed May 2025)
- UK NICE guideline / NHFD and Australia's Hip Fracture Clinical Care Standard: surgery within 36 hours
- Delays in surgery are associated with higher mortality and complications
- Source: WHO Benchmarks for Equitable Hip-Fracture Care (2025)
Orthogeriatric co-management is now standard - joint care by orthopedics and geriatrician:
- Preoperative optimization (fluid balance, anticoagulation reversal, pain control)
- Perioperative delirium prevention (avoid anticholinergics, early mobilization)
- Postoperative rehabilitation and discharge planning
4. Osteoporosis - The Underlying Disease
Secondary fracture prevention is mandatory after any fragility fracture:
- A prior hip fracture is a powerful predictor of a second fracture
- ~50% of patients presenting with hip fracture already had a prior fracture (missed opportunity)
- Anti-osteoporosis treatment reduces fracture risk by 20-50% depending on agent
First-line pharmacological options:
- Bisphosphonates (alendronate, zoledronic acid) - oral or IV; zoledronic acid annual infusion
- Denosumab - subcutaneous injection every 6 months
- Teriparatide / Romosozumab - anabolic agents for very high-risk patients
Key evidence:
- Zoledronic acid initiated within 90 days of hip fracture reduced new clinical fractures by 35% and all-cause mortality by 28% (HORIZON Recurrent Fracture Trial)
- Meta-analysis confirmed 26% reduction in non-vertebral fractures with zoledronic acid (RR 0.74, 95% CI 0.56-0.98)
- Treatment rates globally are abysmally low (11.5% in Germany to 50.3% in UK in a 2023 study)
- Calcium + Vitamin D supplementation is adjunctive to all regimens
- Source: WHO Hip Fracture Benchmarks Textbook (2025)
Fracture Liaison Service (FLS):
- A coordinator-based model to ensure every fragility fracture patient is assessed for osteoporosis and treated
- The gold standard for secondary fracture prevention
5. Perioperative Considerations in Geriatric Fracture Patients
| Issue | Management |
|---|
| Anticoagulation | Reverse warfarin (Vitamin K ± FFP); hold DOACs; bridging strategies |
| Anesthesia choice | Regional (spinal/epidural) preferred over GA - less delirium, lower mortality |
| VTE prophylaxis | LMWH or DOACs post-op; mechanical compression intraoperatively |
| Pain management | Multimodal analgesia; avoid excessive opioids (delirium, constipation, respiratory depression); nerve blocks highly effective |
| Nutritional status | Malnutrition common; affects healing; involve dietitian |
| Delirium prevention | Avoid polypharmacy, early mobilization, maintain sleep-wake cycle, hydration, cognitive stimulation |
| Post-op rehabilitation | Early physiotherapy, weight-bearing as allowed, occupational therapy |
6. The "Second Hip Fracture" Problem
- 20-30% of patients sustain a second hip fracture within 1-2 years if untreated
- Prevention requires: fall risk assessment, home safety review, osteoporosis pharmacotherapy, vitamin D correction, and physiotherapy for balance and strength
QUICK SUMMARY TABLE
| Topic | Key Points |
|---|
| AP Diagnosis | 2 of 3 criteria; lipase >3x ULN preferred over amylase |
| AP Severity | Atlanta 2012: mild/mod-severe/severe; use BISAP, Ranson, CTSI |
| AP Fluids | Aggressive Ringer's Lactate, 250-500 mL/hr |
| AP Nutrition | Early oral feeding <24h; enteral > parenteral |
| AP Antibiotics | Only for confirmed infected necrosis; carbapenems first-line |
| AP Surgery | Step-up approach; ideally delay >4 weeks; open necrosectomy last resort |
| Geriatric Fractures | Fragility = low energy + osteoporosis; hip fracture most deadly |
| Hip Fracture Timing | Surgery within 48h (WHO 2025) or 36h (UK/Australia) |
| Secondary Prevention | Bisphosphonates/denosumab mandatory post-fracture; FLS model |
| Perioperative Care | Orthogeriatric co-management; delirium prevention; regional anesthesia |
Sources: Current Surgical Therapy 14e,
Sleisenger & Fordtran's GI & Liver Disease,
Textbook of Family Medicine 9e,
Campbell's Operative Orthopaedics 15e,
Rockwood & Green's Fractures in Adults 10e,
WHO Benchmarks for Equitable Hip-Fracture Care (2025);
ACG AP Guidelines 2024;
IAP/APA Revised AP Guidelines 2025